Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04938492 · ClinicalTrials.gov registry record · NA
The Association Between Loneliness and Substance Use
A NA study of Opioid Use and Loneliness, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT04938492: Completed NA study of Opioid Use and Loneliness, sponsored by University of Rochester.
NCT04938492 is a NA study of Opioid Use and Loneliness that has completed, run by University of Rochester. The registered enrollment target is 125 participants, below the 148,259-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04938492, a NA study of Opioid Use and Loneliness, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study will determine if cognitive behavioral therapy will help improve loneliness in people who use opioids.
Primary Outcome
Loneliness will be measured using the University of California-Los Angeles (UCLA) Loneliness Scale. A 20-item scale designed to measure one's subjective feelings of loneliness as well as feelings of social isolation. Participants rate each item as 1 (never), 2 (rarely), 3 (sometimes) or 4 (often). The scores range from 20-80 with higher scores indicating worse outcome.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy for loneliness (CBT-L)
- BEHAVIORAL Physical Health Education Training (PHET)
Study Locations (1)
New York
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2021-08-12 |
| Est. Completion | 2023-07-01 |
| Phase | NA |
What the finished NCT04938492 record still lists
NCT04938492 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 148,259-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Opioid Use appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy for loneliness (CBT-L) is the first listed.
NCT04938492 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04938492 about?
NCT04938492 is a clinical study titled "The Association Between Loneliness and Substance Use". The proposed study will determine if cognitive behavioral therapy will help improve loneliness in people who use opioids.
What is the current status of trial NCT04938492?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2021-08-12. Estimated completion is 2023-07-01.
What conditions does trial NCT04938492 study?
This clinical trial studies the following conditions: Opioid Use, Loneliness.
What interventions are being tested in trial NCT04938492?
The interventions under investigation include: Cognitive Behavioral Therapy for loneliness (CBT-L) (BEHAVIORAL), Physical Health Education Training (PHET) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04938492?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04938492 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04938492's enrollment target sits among peer trials
125 57th of 105 higher than 49 of 105 other Opioid Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
QL vs LAI for Palatoplasty
RECRUITING · NA
-
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
RECRUITING · NA
-
Hip Arthroscopy Postoperative Opioid Demands
RECRUITING · NA
-
Neuroimaging of Opioid Phase (OPAL)
RECRUITING · NA
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI